Aerovate Therapeutics Inc. (AVTE) NASDAQ
$16.64 0.34 (2.09%)
Market Cap: $414.67M
As of 06/07/23 04:00 PM EDT. Market closed.

Aerovate Therapeutics Inc. (AVTE)
NASDAQ
$16.64
0.34 (2.09%)
Market Cap: $414.67M
As of 06/07/23 04:00 PM EDT. Market closed.
Aerovate is a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease. Aerovate's initial focus is on advancing AV-101, its dry powder inhaled formulation of the drug imatinib for the treatment of pulmonary arterial hypertension, or ... read more
Aerovate is a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease. Aerovate's initial focus is on advancing AV-101, its dry powder inhaled formulation of the drug imatinib for the treatment of pulmonary arterial hypertension, or PAH. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Jun 05, 2023 | Option Exercise | $2.02 | 2,250 | 4,555 | 3,859 | Jun 07, 2023, 06:00 PM |
NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Jun 05, 2023 | Sale | $16.26 | 2,250 | 36,576 | 1,609 | Jun 07, 2023, 06:00 PM |
Gillies Hunter | CHIEF MEDICAL OFFICER | May 19, 2023 | Option Exercise | $1.74 | 65 | 113 | 3,316 | May 23, 2023, 06:00 PM |
Gillies Hunter | CHIEF MEDICAL OFFICER | May 19, 2023 | Sale | $19.50 | 65 | 1,268 | 3,251 | May 23, 2023, 06:00 PM |
Gillies Hunter | CHIEF MEDICAL OFFICER | May 17, 2023 | Option Exercise | $1.74 | 1,090 | 1,897 | 4,341 | May 19, 2023, 06:00 PM |
Gillies Hunter | CHIEF MEDICAL OFFICER | May 17, 2023 | Sale | $19.59 | 1,090 | 21,356 | 3,251 | May 19, 2023, 06:00 PM |
NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | May 05, 2023 | Option Exercise | $2.02 | 2,250 | 4,555 | 3,859 | May 09, 2023, 06:00 PM |
NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | May 05, 2023 | Sale | $20.87 | 2,250 | 46,957 | 1,814 | May 09, 2023, 06:00 PM |
Dake Benjamin T | SEE REMARKS | May 08, 2023 | Option Exercise | $2.05 | 10,284 | 21,043 | 11,575 | May 09, 2023, 06:00 PM |
Dake Benjamin T | SEE REMARKS | May 08, 2023 | Sale | $21.80 | 10,284 | 224,160 | 2,890 | May 09, 2023, 06:00 PM |
Verwijs Marinus | SENIOR VICE PRESIDENT, CMC | May 03, 2023 | Sale | $20.79 | 759 | 15,779 | 0 | May 05, 2023, 06:00 PM |
NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | May 01, 2023 | Option Exercise | $2.14 | 15,000 | 32,100 | 15,693 | May 03, 2023, 06:00 PM |
NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | May 02, 2023 | Sale | $21.15 | 693 | 14,657 | 0 | May 03, 2023, 06:00 PM |
NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | May 01, 2023 | Sale | $20.61 | 15,000 | 309,088 | 693 | May 03, 2023, 06:00 PM |
Gillies Hunter | CHIEF MEDICAL OFFICER | Apr 21, 2023 | Option Exercise | $1.74 | 4,000 | 6,960 | 5,960 | Apr 25, 2023, 06:00 PM |
Gillies Hunter | CHIEF MEDICAL OFFICER | Apr 21, 2023 | Sale | $19.50 | 4,000 | 78,000 | 1,960 | Apr 25, 2023, 06:00 PM |
Dake Benjamin T | SEE REMARKS | Apr 06, 2023 | Option Exercise | $2.05 | 10,283 | 21,041 | 10,283 | Apr 07, 2023, 06:00 PM |
Dake Benjamin T | SEE REMARKS | Apr 06, 2023 | Sale | $18.17 | 10,283 | 186,829 | 0 | Apr 07, 2023, 06:00 PM |
NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Apr 05, 2023 | Option Exercise | $2.02 | 2,250 | 4,555 | 3,859 | Apr 07, 2023, 06:00 PM |
NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Apr 05, 2023 | Sale | $18.20 | 2,250 | 40,942 | 2,144 | Apr 07, 2023, 06:00 PM |
NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | Apr 03, 2023 | Option Exercise | $2.14 | 15,000 | 32,100 | 15,000 | Apr 05, 2023, 06:00 PM |
NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | Apr 03, 2023 | Sale | $19.39 | 15,000 | 290,916 | 5,828 | Apr 05, 2023, 06:00 PM |
Dake Benjamin T | SEE REMARKS | Mar 06, 2023 | Option Exercise | $2.05 | 10,282 | 21,039 | 10,282 | Mar 08, 2023, 06:00 PM |
Dake Benjamin T | SEE REMARKS | Mar 06, 2023 | Sale | $23.73 | 10,282 | 243,954 | 215 | Mar 08, 2023, 06:00 PM |
NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Mar 06, 2023 | Option Exercise | $2.02 | 2,250 | 4,555 | 3,859 | Mar 08, 2023, 06:00 PM |
NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Mar 06, 2023 | Sale | $23.75 | 2,250 | 53,440 | 1,654 | Mar 08, 2023, 06:00 PM |
NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | Mar 01, 2023 | Option Exercise | $2.14 | 15,000 | 32,100 | 15,000 | Mar 03, 2023, 06:00 PM |
NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | Mar 01, 2023 | Sale | $23.81 | 15,000 | 357,196 | 9,038 | Mar 03, 2023, 06:00 PM |
Dake Benjamin T | SEE REMARKS | Feb 06, 2023 | Option Exercise | $2.05 | 10,284 | 21,043 | 10,284 | Feb 08, 2023, 06:00 PM |
Dake Benjamin T | SEE REMARKS | Feb 06, 2023 | Sale | $24.59 | 10,284 | 252,881 | 1,426 | Feb 08, 2023, 06:00 PM |
NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Feb 06, 2023 | Option Exercise | $2.02 | 2,250 | 4,555 | 3,859 | Feb 08, 2023, 06:00 PM |
NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Feb 06, 2023 | Sale | $24.27 | 2,250 | 54,612 | 1,609 | Feb 08, 2023, 06:00 PM |
NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | Feb 01, 2023 | Option Exercise | $2.14 | 15,000 | 32,100 | 15,000 | Feb 03, 2023, 06:00 PM |
NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | Feb 01, 2023 | Sale | $22.68 | 15,000 | 340,197 | 4,495 | Feb 03, 2023, 06:00 PM |
Dake Benjamin T | SEE REMARKS | Jan 06, 2023 | Option Exercise | $2.05 | 10,284 | 21,043 | 10,284 | Jan 09, 2023, 06:00 PM |
Dake Benjamin T | SEE REMARKS | Jan 06, 2023 | Sale | $25.98 | 10,284 | 267,203 | 2,792 | Jan 09, 2023, 06:00 PM |
NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Jan 05, 2023 | Option Exercise | $2.02 | 2,250 | 4,555 | 3,859 | Jan 09, 2023, 06:00 PM |
NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Jan 05, 2023 | Sale | $26.40 | 2,250 | 59,405 | 1,609 | Jan 09, 2023, 06:00 PM |
NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | Jan 03, 2023 | Option Exercise | $2.14 | 15,000 | 32,100 | 15,000 | Jan 05, 2023, 05:00 PM |
NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | Jan 03, 2023 | Sale | $27.07 | 15,000 | 406,076 | 3,073 | Jan 05, 2023, 05:00 PM |
Dake Benjamin T | SEE REMARKS | Dec 12, 2022 | Option Exercise | $2.14 | 2,059 | 4,406 | 2,059 | Dec 14, 2022, 06:00 PM |
Dake Benjamin T | SEE REMARKS | Dec 12, 2022 | Sale | $29.43 | 2,059 | 60,591 | 2,039 | Dec 14, 2022, 06:00 PM |
Eldridge George A | SEE REMARKS | Dec 12, 2022 | Option Exercise | $2.14 | 10,000 | 21,400 | 11,960 | Dec 13, 2022, 06:00 PM |
Eldridge George A | SEE REMARKS | Dec 09, 2022 | Option Exercise | $2.14 | 3,969 | 8,494 | 5,929 | Dec 13, 2022, 06:00 PM |
Eldridge George A | SEE REMARKS | Dec 09, 2022 | Sale | $24.38 | 3,969 | 96,765 | 2,543 | Dec 13, 2022, 06:00 PM |
Eldridge George A | SEE REMARKS | Dec 12, 2022 | Sale | $30.04 | 10,000 | 300,428 | 1,960 | Dec 13, 2022, 06:00 PM |
Dake Benjamin T | SEE REMARKS | Dec 09, 2022 | Option Exercise | $2.14 | 394 | 843 | 394 | Dec 12, 2022, 06:00 PM |
Dake Benjamin T | SEE REMARKS | Dec 08, 2022 | Option Exercise | $2.14 | 10,000 | 21,400 | 10,000 | Dec 12, 2022, 06:00 PM |
Dake Benjamin T | SEE REMARKS | Dec 09, 2022 | Sale | $25.03 | 394 | 9,861 | 0 | Dec 12, 2022, 06:00 PM |
Dake Benjamin T | SEE REMARKS | Dec 08, 2022 | Sale | $22.64 | 10,000 | 226,449 | 9,072 | Dec 12, 2022, 06:00 PM |
Eldridge George A | SEE REMARKS | Dec 08, 2022 | Option Exercise | $2.14 | 12,011 | 25,704 | 13,971 | Dec 09, 2022, 06:00 PM |
Eldridge George A | SEE REMARKS | Dec 07, 2022 | Option Exercise | $2.14 | 11,637 | 24,903 | 13,597 | Dec 09, 2022, 06:00 PM |
Eldridge George A | SEE REMARKS | Dec 08, 2022 | Sale | $23.87 | 12,011 | 286,700 | 13,011 | Dec 09, 2022, 06:00 PM |
Eldridge George A | SEE REMARKS | Dec 07, 2022 | Sale | $19.77 | 11,637 | 230,083 | 6,518 | Dec 09, 2022, 06:00 PM |
Dake Benjamin T | SEE REMARKS | Dec 06, 2022 | Option Exercise | $2.12 | 40,000 | 84,635 | 40,000 | Dec 08, 2022, 06:00 PM |
Dake Benjamin T | SEE REMARKS | Dec 06, 2022 | Sale | $17.67 | 40,000 | 706,772 | 37,989 | Dec 08, 2022, 06:00 PM |
NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Dec 05, 2022 | Option Exercise | $2.02 | 2,250 | 4,555 | 3,859 | Dec 07, 2022, 06:00 PM |
NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Dec 05, 2022 | Sale | $17.38 | 2,250 | 39,114 | 1,609 | Dec 07, 2022, 06:00 PM |
NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | Dec 01, 2022 | Option Exercise | $2.14 | 15,000 | 32,100 | 15,000 | Dec 02, 2022, 07:00 PM |
NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | Dec 01, 2022 | Sale | $18.00 | 15,000 | 270,000 | 0 | Dec 02, 2022, 07:00 PM |
Eldridge George A | SEE REMARKS | Nov 30, 2022 | Option Exercise | $2.14 | 85 | 182 | 2,045 | Dec 02, 2022, 07:00 PM |
Eldridge George A | SEE REMARKS | Nov 30, 2022 | Sale | $19.06 | 85 | 1,620 | 1,960 | Dec 02, 2022, 07:00 PM |
Eldridge George A | SEE REMARKS | Nov 23, 2022 | Option Exercise | $2.14 | 1,261 | 2,699 | 3,221 | Nov 28, 2022, 05:00 PM |
Eldridge George A | SEE REMARKS | Nov 23, 2022 | Sale | $19.07 | 1,261 | 24,048 | 1,960 | Nov 28, 2022, 05:00 PM |
Eldridge George A | SEE REMARKS | Nov 22, 2022 | Option Exercise | $2.14 | 174 | 372 | 2,134 | Nov 22, 2022, 08:00 PM |
Eldridge George A | SEE REMARKS | Nov 21, 2022 | Option Exercise | $2.14 | 2 | 4 | 1,962 | Nov 22, 2022, 08:00 PM |
Eldridge George A | SEE REMARKS | Nov 18, 2022 | Option Exercise | $2.14 | 861 | 1,843 | 2,821 | Nov 22, 2022, 08:00 PM |
Eldridge George A | SEE REMARKS | Nov 22, 2022 | Sale | $19.01 | 174 | 3,308 | 1,960 | Nov 22, 2022, 08:00 PM |
Eldridge George A | SEE REMARKS | Nov 21, 2022 | Sale | $19.00 | 2 | 38 | 1,960 | Nov 22, 2022, 08:00 PM |
Eldridge George A | SEE REMARKS | Nov 18, 2022 | Sale | $19.52 | 861 | 16,805 | 2,041 | Nov 22, 2022, 08:00 PM |
Dake Benjamin T | SEE REMARKS | Nov 11, 2022 | Option Exercise | $2.14 | 6,198 | 13,264 | 6,198 | Nov 14, 2022, 05:00 PM |
Dake Benjamin T | SEE REMARKS | Nov 10, 2022 | Option Exercise | $2.14 | 1,800 | 3,852 | 1,800 | Nov 14, 2022, 05:00 PM |
Dake Benjamin T | SEE REMARKS | Nov 09, 2022 | Option Exercise | $2.14 | 14,000 | 29,960 | 14,000 | Nov 14, 2022, 05:00 PM |
Dake Benjamin T | SEE REMARKS | Nov 11, 2022 | Sale | $20.69 | 6,198 | 128,236 | 1,746 | Nov 14, 2022, 05:00 PM |
Dake Benjamin T | SEE REMARKS | Nov 10, 2022 | Sale | $20.10 | 1,800 | 36,172 | 0 | Nov 14, 2022, 05:00 PM |
Dake Benjamin T | SEE REMARKS | Nov 09, 2022 | Sale | $17.91 | 14,000 | 250,677 | 0 | Nov 14, 2022, 05:00 PM |
Dake Benjamin T | SEE REMARKS | Nov 08, 2022 | Option Exercise | $2.14 | 8,373 | 17,918 | 8,373 | Nov 09, 2022, 05:00 PM |
Dake Benjamin T | SEE REMARKS | Nov 07, 2022 | Option Exercise | $2.09 | 17,627 | 36,757 | 17,627 | Nov 09, 2022, 05:00 PM |
Dake Benjamin T | SEE REMARKS | Nov 08, 2022 | Sale | $18.09 | 8,373 | 151,458 | 0 | Nov 09, 2022, 05:00 PM |
Dake Benjamin T | SEE REMARKS | Nov 07, 2022 | Sale | $18.32 | 17,627 | 322,894 | 6,505 | Nov 09, 2022, 05:00 PM |
NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Nov 07, 2022 | Option Exercise | $2.02 | 2,250 | 4,555 | 3,859 | Nov 09, 2022, 05:00 PM |
NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Nov 07, 2022 | Sale | $19.20 | 2,250 | 43,194 | 3,409 | Nov 09, 2022, 05:00 PM |
NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | Nov 01, 2022 | Sale | $19.50 | 1,038 | 20,241 | 0 | Nov 03, 2022, 05:00 PM |
Verwijs Marinus | SENIOR VICE PRESIDENT, CMC | Nov 02, 2022 | Sale | $18.89 | 1,130 | 21,346 | 0 | Nov 03, 2022, 05:00 PM |
Dake Benjamin T | SEE REMARKS | Oct 18, 2022 | Option Exercise | $2.14 | 5,705 | 12,209 | 5,705 | Oct 20, 2022, 05:00 PM |
Dake Benjamin T | SEE REMARKS | Oct 18, 2022 | Sale | $21.08 | 5,705 | 120,287 | 0 | Oct 20, 2022, 05:00 PM |
Dake Benjamin T | SEE REMARKS | Oct 14, 2022 | Option Exercise | $2.14 | 110 | 235 | 110 | Oct 18, 2022, 05:01 PM |
Dake Benjamin T | SEE REMARKS | Oct 17, 2022 | Option Exercise | $2.14 | 4,185 | 8,956 | 4,185 | Oct 18, 2022, 05:01 PM |
Dake Benjamin T | SEE REMARKS | Oct 17, 2022 | Sale | $20.16 | 4,185 | 84,380 | 0 | Oct 18, 2022, 05:01 PM |
Dake Benjamin T | SEE REMARKS | Oct 14, 2022 | Sale | $20.05 | 110 | 2,205 | 0 | Oct 18, 2022, 05:01 PM |
Dake Benjamin T | SEE REMARKS | Oct 10, 2022 | Option Exercise | $2.14 | 4,954 | 10,602 | 4,954 | Oct 12, 2022, 05:00 PM |
Dake Benjamin T | SEE REMARKS | Oct 10, 2022 | Sale | $16.89 | 4,954 | 83,681 | 1,430 | Oct 12, 2022, 05:00 PM |
Dake Benjamin T | SEE REMARKS | Oct 06, 2022 | Option Exercise | $2.07 | 13,040 | 26,941 | 13,040 | Oct 11, 2022, 05:00 PM |
Dake Benjamin T | SEE REMARKS | Oct 07, 2022 | Option Exercise | $2.14 | 10,520 | 22,513 | 10,520 | Oct 11, 2022, 05:00 PM |
Dake Benjamin T | SEE REMARKS | Oct 07, 2022 | Sale | $16.01 | 10,520 | 168,460 | 1,757 | Oct 11, 2022, 05:00 PM |
Dake Benjamin T | SEE REMARKS | Oct 06, 2022 | Sale | $15.82 | 13,040 | 206,344 | 1,830 | Oct 11, 2022, 05:00 PM |
NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Oct 05, 2022 | Option Exercise | $2.02 | 2,250 | 4,555 | 3,859 | Oct 07, 2022, 05:00 PM |
NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Oct 05, 2022 | Sale | $15.75 | 2,250 | 35,447 | 1,800 | Oct 07, 2022, 05:00 PM |
Dake Benjamin T | SEE REMARKS | Sep 12, 2022 | Option Exercise | $2.14 | 7,520 | 16,093 | 7,520 | Sep 14, 2022, 05:15 PM |
Dake Benjamin T | SEE REMARKS | Sep 12, 2022 | Sale | $17.33 | 7,520 | 130,307 | 2,248 | Sep 14, 2022, 05:15 PM |
Dake Benjamin T | See Remarks | Sep 08, 2022 | Option Exercise | $1.74 | 3,120 | 5,429 | 3,120 | Sep 12, 2022, 05:30 PM |
Dake Benjamin T | See Remarks | Sep 09, 2022 | Option Exercise | $2.12 | 4,720 | 9,998 | 4,720 | Sep 12, 2022, 05:30 PM |
Dake Benjamin T | See Remarks | Sep 08, 2022 | Sale | $18.20 | 3,120 | 56,782 | 629 | Sep 12, 2022, 05:30 PM |
Dake Benjamin T | See Remarks | Sep 09, 2022 | Sale | $17.54 | 4,720 | 82,803 | 176 | Sep 12, 2022, 05:30 PM |
Dake Benjamin T | See Remarks | Sep 07, 2022 | Option Exercise | $1.74 | 8,220 | 14,303 | 8,220 | Sep 08, 2022, 05:30 PM |
Dake Benjamin T | See Remarks | Sep 06, 2022 | Option Exercise | $1.74 | 9,166 | 15,949 | 9,166 | Sep 08, 2022, 05:30 PM |
Dake Benjamin T | See Remarks | Sep 07, 2022 | Sale | $18.42 | 3,663 | 67,477 | 3,658 | Sep 08, 2022, 05:30 PM |
Dake Benjamin T | See Remarks | Sep 06, 2022 | Sale | $18.53 | 9,166 | 169,876 | 4,744 | Sep 08, 2022, 05:30 PM |
NIVEN RALPH | Chief Scientific Officer | Sep 06, 2022 | Option Exercise | $2.02 | 2,250 | 4,555 | 3,859 | Sep 07, 2022, 05:30 PM |
NIVEN RALPH | Chief Scientific Officer | Sep 06, 2022 | Sale | $19.00 | 2,250 | 42,750 | 1,609 | Sep 07, 2022, 05:30 PM |
NIVEN RALPH | Chief Scientific Officer | Aug 18, 2022 | Option Exercise | $2.02 | 2,250 | 4,555 | 3,859 | Aug 19, 2022, 05:00 PM |
NIVEN RALPH | Chief Scientific Officer | Aug 18, 2022 | Sale | $21.18 | 2,250 | 47,657 | 1,609 | Aug 19, 2022, 05:00 PM |
Dake Benjamin T | See Remarks | Aug 16, 2022 | Option Exercise | $1.74 | 21,000 | 36,540 | 21,000 | Aug 18, 2022, 05:00 PM |
Dake Benjamin T | See Remarks | Aug 16, 2022 | Sale | $23.00 | 21,000 | 482,932 | 10,525 | Aug 18, 2022, 05:00 PM |
Dake Benjamin T | See Remarks | Aug 11, 2022 | Option Exercise | $1.74 | 1,347 | 2,344 | 1,347 | Aug 12, 2022, 05:15 PM |
Dake Benjamin T | See Remarks | Aug 10, 2022 | Option Exercise | $1.74 | 12,720 | 22,133 | 12,720 | Aug 12, 2022, 05:15 PM |
Dake Benjamin T | See Remarks | Aug 11, 2022 | Sale | $23.93 | 1,347 | 32,232 | 79 | Aug 12, 2022, 05:15 PM |
Dake Benjamin T | See Remarks | Aug 10, 2022 | Sale | $24.09 | 12,720 | 306,366 | 780 | Aug 12, 2022, 05:15 PM |
Dake Benjamin T | See Remarks | Aug 08, 2022 | Option Exercise | $1.74 | 6,943 | 12,081 | 6,943 | Aug 10, 2022, 05:15 PM |
Dake Benjamin T | See Remarks | Aug 09, 2022 | Option Exercise | $1.74 | 8,700 | 15,138 | 8,700 | Aug 10, 2022, 05:15 PM |
Dake Benjamin T | See Remarks | Aug 09, 2022 | Sale | $24.06 | 8,700 | 209,325 | 2,791 | Aug 10, 2022, 05:15 PM |
Dake Benjamin T | See Remarks | Aug 08, 2022 | Sale | $24.62 | 6,943 | 170,962 | 2,954 | Aug 10, 2022, 05:15 PM |
Cormorant Asset Management, LP | Former 10% Owner | Jul 02, 2021 | Buy | $14.00 | 500,000 | 7,000,000 | 2,030,691 | Jul 07, 2021, 04:45 PM |
RA CAPITAL MANAGEMENT, L.P. | Director | Jul 02, 2021 | Buy | $14.00 | 2,785,714 | 38,999,996 | 6,965,568 | Jul 06, 2021, 05:03 PM |
Sofinnova Venture Partners X, L.P. | 10% Owner | Jul 02, 2021 | Buy | $14.00 | 357,142 | 4,999,988 | 3,758,686 | Jul 06, 2021, 04:28 PM |
Katabi Maha | Director | Jul 02, 2021 | Buy | $14.00 | 357,142 | 4,999,988 | 3,758,686 | Jul 06, 2021, 04:27 PM |
GRAYZEL DAVID S. | Director | Jul 02, 2021 | Buy | $14.00 | 535,714 | 7,499,996 | 3,103,879 | Jul 06, 2021, 04:27 PM |
Atlas Venture Fund XII, L.P. | 10% Owner | Jul 02, 2021 | Buy | $14.00 | 535,714 | 7,499,996 | 3,103,879 | Jul 06, 2021, 04:26 PM |
Owner | Relationship | Date | Value($) |
NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 06/05/2023 | 4,555 |
NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 06/05/2023 | 36,576 |
Gillies Hunter | CHIEF MEDICAL OFFICER | 05/19/2023 | 113 |
Gillies Hunter | CHIEF MEDICAL OFFICER | 05/19/2023 | 1,268 |
Gillies Hunter | CHIEF MEDICAL OFFICER | 05/17/2023 | 1,897 |
Gillies Hunter | CHIEF MEDICAL OFFICER | 05/17/2023 | 21,356 |
NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 05/05/2023 | 4,555 |
NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 05/05/2023 | 46,957 |
Dake Benjamin T | SEE REMARKS | 05/08/2023 | 21,043 |
Dake Benjamin T | SEE REMARKS | 05/08/2023 | 224,160 |
Verwijs Marinus | SENIOR VICE PRESIDENT, CMC | 05/03/2023 | 15,779 |
NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 05/01/2023 | 32,100 |
NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 05/02/2023 | 14,657 |
NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 05/01/2023 | 309,088 |
Gillies Hunter | CHIEF MEDICAL OFFICER | 04/21/2023 | 6,960 |
Gillies Hunter | CHIEF MEDICAL OFFICER | 04/21/2023 | 78,000 |
Dake Benjamin T | SEE REMARKS | 04/06/2023 | 21,041 |
Dake Benjamin T | SEE REMARKS | 04/06/2023 | 186,829 |
NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 04/05/2023 | 4,555 |
NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 04/05/2023 | 40,942 |
NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 04/03/2023 | 32,100 |
NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 04/03/2023 | 290,916 |
Dake Benjamin T | SEE REMARKS | 03/06/2023 | 21,039 |
Dake Benjamin T | SEE REMARKS | 03/06/2023 | 243,954 |
NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 03/06/2023 | 4,555 |
NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 03/06/2023 | 53,440 |
NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 03/01/2023 | 32,100 |
NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 03/01/2023 | 357,196 |
Dake Benjamin T | SEE REMARKS | 02/06/2023 | 21,043 |
Dake Benjamin T | SEE REMARKS | 02/06/2023 | 252,881 |
NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 02/06/2023 | 4,555 |
NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 02/06/2023 | 54,612 |
NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 02/01/2023 | 32,100 |
NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 02/01/2023 | 340,197 |
Dake Benjamin T | SEE REMARKS | 01/06/2023 | 21,043 |
Dake Benjamin T | SEE REMARKS | 01/06/2023 | 267,203 |
NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 01/05/2023 | 4,555 |
NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 01/05/2023 | 59,405 |
NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 01/03/2023 | 32,100 |
NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 01/03/2023 | 406,076 |
Dake Benjamin T | SEE REMARKS | 12/12/2022 | 4,406 |
Dake Benjamin T | SEE REMARKS | 12/12/2022 | 60,591 |
Eldridge George A | SEE REMARKS | 12/12/2022 | 21,400 |
Eldridge George A | SEE REMARKS | 12/09/2022 | 8,494 |
Eldridge George A | SEE REMARKS | 12/09/2022 | 96,765 |
Eldridge George A | SEE REMARKS | 12/12/2022 | 300,428 |
Dake Benjamin T | SEE REMARKS | 12/09/2022 | 843 |
Dake Benjamin T | SEE REMARKS | 12/08/2022 | 21,400 |
Dake Benjamin T | SEE REMARKS | 12/09/2022 | 9,861 |
Dake Benjamin T | SEE REMARKS | 12/08/2022 | 226,449 |
Eldridge George A | SEE REMARKS | 12/08/2022 | 25,704 |
Eldridge George A | SEE REMARKS | 12/07/2022 | 24,903 |
Eldridge George A | SEE REMARKS | 12/08/2022 | 286,700 |
Eldridge George A | SEE REMARKS | 12/07/2022 | 230,083 |
Dake Benjamin T | SEE REMARKS | 12/06/2022 | 84,635 |
Dake Benjamin T | SEE REMARKS | 12/06/2022 | 706,772 |
NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 12/05/2022 | 4,555 |
NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 12/05/2022 | 39,114 |
NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 12/01/2022 | 32,100 |
NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 12/01/2022 | 270,000 |
Eldridge George A | SEE REMARKS | 11/30/2022 | 182 |
Eldridge George A | SEE REMARKS | 11/30/2022 | 1,620 |
Eldridge George A | SEE REMARKS | 11/23/2022 | 2,699 |
Eldridge George A | SEE REMARKS | 11/23/2022 | 24,048 |
Eldridge George A | SEE REMARKS | 11/22/2022 | 372 |
Eldridge George A | SEE REMARKS | 11/21/2022 | 4 |
Eldridge George A | SEE REMARKS | 11/18/2022 | 1,843 |
Eldridge George A | SEE REMARKS | 11/22/2022 | 3,308 |
Eldridge George A | SEE REMARKS | 11/21/2022 | 38 |
Eldridge George A | SEE REMARKS | 11/18/2022 | 16,805 |
Dake Benjamin T | SEE REMARKS | 11/11/2022 | 13,264 |
Dake Benjamin T | SEE REMARKS | 11/10/2022 | 3,852 |
Dake Benjamin T | SEE REMARKS | 11/09/2022 | 29,960 |
Dake Benjamin T | SEE REMARKS | 11/11/2022 | 128,236 |
Dake Benjamin T | SEE REMARKS | 11/10/2022 | 36,172 |
Dake Benjamin T | SEE REMARKS | 11/09/2022 | 250,677 |
Dake Benjamin T | SEE REMARKS | 11/08/2022 | 17,918 |
Dake Benjamin T | SEE REMARKS | 11/07/2022 | 36,757 |
Dake Benjamin T | SEE REMARKS | 11/08/2022 | 151,458 |
Dake Benjamin T | SEE REMARKS | 11/07/2022 | 322,894 |
NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 11/07/2022 | 4,555 |
NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 11/07/2022 | 43,194 |
NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 11/01/2022 | 20,241 |
Verwijs Marinus | SENIOR VICE PRESIDENT, CMC | 11/02/2022 | 21,346 |
Dake Benjamin T | SEE REMARKS | 10/18/2022 | 12,209 |
Dake Benjamin T | SEE REMARKS | 10/18/2022 | 120,287 |
Dake Benjamin T | SEE REMARKS | 10/14/2022 | 235 |
Dake Benjamin T | SEE REMARKS | 10/17/2022 | 8,956 |
Dake Benjamin T | SEE REMARKS | 10/17/2022 | 84,380 |
Dake Benjamin T | SEE REMARKS | 10/14/2022 | 2,205 |
Dake Benjamin T | SEE REMARKS | 10/10/2022 | 10,602 |
Dake Benjamin T | SEE REMARKS | 10/10/2022 | 83,681 |
Dake Benjamin T | SEE REMARKS | 10/06/2022 | 26,941 |
Dake Benjamin T | SEE REMARKS | 10/07/2022 | 22,513 |
Dake Benjamin T | SEE REMARKS | 10/07/2022 | 168,460 |
Dake Benjamin T | SEE REMARKS | 10/06/2022 | 206,344 |
NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 10/05/2022 | 4,555 |
NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 10/05/2022 | 35,447 |
Dake Benjamin T | SEE REMARKS | 09/12/2022 | 16,093 |
Dake Benjamin T | SEE REMARKS | 09/12/2022 | 130,307 |
Dake Benjamin T | See Remarks | 09/08/2022 | 5,429 |
Dake Benjamin T | See Remarks | 09/09/2022 | 9,998 |
Dake Benjamin T | See Remarks | 09/08/2022 | 56,782 |
Dake Benjamin T | See Remarks | 09/09/2022 | 82,803 |
Dake Benjamin T | See Remarks | 09/07/2022 | 14,303 |
Dake Benjamin T | See Remarks | 09/06/2022 | 15,949 |
Dake Benjamin T | See Remarks | 09/07/2022 | 67,477 |
Dake Benjamin T | See Remarks | 09/06/2022 | 169,876 |
NIVEN RALPH | Chief Scientific Officer | 09/06/2022 | 4,555 |
NIVEN RALPH | Chief Scientific Officer | 09/06/2022 | 42,750 |
NIVEN RALPH | Chief Scientific Officer | 08/18/2022 | 4,555 |
NIVEN RALPH | Chief Scientific Officer | 08/18/2022 | 47,657 |
Dake Benjamin T | See Remarks | 08/16/2022 | 36,540 |
Dake Benjamin T | See Remarks | 08/16/2022 | 482,932 |
Dake Benjamin T | See Remarks | 08/11/2022 | 2,344 |
Dake Benjamin T | See Remarks | 08/10/2022 | 22,133 |
Dake Benjamin T | See Remarks | 08/11/2022 | 32,232 |
Dake Benjamin T | See Remarks | 08/10/2022 | 306,366 |
Dake Benjamin T | See Remarks | 08/08/2022 | 12,081 |
Dake Benjamin T | See Remarks | 08/09/2022 | 15,138 |
Dake Benjamin T | See Remarks | 08/09/2022 | 209,325 |
Dake Benjamin T | See Remarks | 08/08/2022 | 170,962 |
Cormorant Asset Management, LP | Former 10% Owner | 07/02/2021 | 7,000,000 |
RA CAPITAL MANAGEMENT, L.P. | Director | 07/02/2021 | 38,999,996 |
Sofinnova Venture Partners X, L.P. | 10% Owner | 07/02/2021 | 4,999,988 |
Katabi Maha | Director | 07/02/2021 | 4,999,988 |
GRAYZEL DAVID S. | Director | 07/02/2021 | 7,499,996 |
Atlas Venture Fund XII, L.P. | 10% Owner | 07/02/2021 | 7,499,996 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
RA CAPITAL MANAGEMENT, L.P. | 8,263,982 | 3.77% | No change | Other |
BAKER BROS. ADVISORS LP | 1,963,479 | 0.22% | -0.68% | Other |
ORBIMED ADVISORS LLC | 756,930 | 0.3% | -0.34% | Other |
BLACKROCK INC. | 599,999 | 0.00036% | -1.31% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 187,499 | 0.00049% | 4.98% | Other |
D. E. SHAW & CO., INC. | 15,958 | 0.00034% | -45.89% | Other |
CHEYNE CAPITAL MANAGEMENT (UK) LLP | 18,927 | 0.97% | Exited | Event Driven |
RENAISSANCE TECHNOLOGIES LLC | 17,600 | 0.00047% | -2.76% | Other |
ALPS ADVISORS INC | 16,208 | 0.00289% | -2.86% | Other |
Period of Report: 12/31/2022
10-K/10-Q Filings: View